Breast Cancer Risk Tools Are Getting Closer to Patients — But the Evidence Still Matters
New AI-powered breast cancer risk tools are moving beyond the clinic and into patient-facing apps, but experts still urge caution about accuracy, equity, and how results should guide screening.